Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study

Atherosclerosis

Volumn 119, Issue 1, 1996, Pages 119-127

  Lane, A ^a   Green, F ^a   Scarabin, P Y ^b   Nicaud, V ^b   Bara, L ^c   Humphries, S ^a   Evans, A ^d   Luc, G ^e   Cambou, J P ^f   Arveiler, D ^g   Cambien, F ^h  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HÔPITAL BROUSSAIS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d MONICA Project   (United Kingdom)

^e MONICA Project   (France)

^f MONICA Project   (France)

^g MONICA Project   (France)

^h NONE   (France)

Author keywords

ECTIM; Factor VII Arg Gln353 polymorphism; Factor VII coagulant activity; MI risk factors; Thrombosis risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 7; CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; FRANCE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; UNITED KINGDOM;

ADULT; BLOOD COAGULATION; CASE-CONTROL STUDIES; FACTOR VII; FRANCE; HUMANS; IRELAND; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0030066703     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05638-6     Document Type: Article

References (27)

1. Broze GJ Jr., Majerus PW. Purification and properties of human coagulation Factor VII. J Biol Chem 1980;255:1242.
2. Rao L, Vijaya M, Rapaport S. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988;85:6687.
3. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;ii:533.
4. Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVII in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985;59:249.
5. Simpson HCR, Meade TW, Stirling Y, Mann JI, Chakrabarti RR, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983;ii:786.
6. Scarabin PY, Bara L, Samama M, Orssaud G. Further evidence that activated factor VII is related to plasma lipids. Br J Haematol 1985;61:186.
7. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity, a predictor of cardiovascular mortality. Atherosclerosis 1986;60:269.
8. Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990;57:541.
9. Carvalho de Sousa J, Soria C, Ayrault-Jarrier Marise, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988;41:940.
10. Carvalho de Sousa J, Bruckert E, Giral P, Soria C Chapman J, Truffert J, Dairou F, de Gennes JL, Caen JP. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 1989;19:125.
11. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscl Thromb 1994;14:60.
12. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991;86:163.
13. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 1992;95:119.
14. Green F, Kelleher C, Wilkes H, Temple A, Meade T Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arteriosclerosis 1991;11:540.
15. Lane A, Cruickshank JK, Mitchell J, Henderson A Humphries S, Green f. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of CHD. Atherosclerosis 1992;94:43.
16. Humphries S, Lane A, Green F, Cooper J, Miller G. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994;14:193.
17. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993;13:886.
18. The WHO MONICA Project: a worldwide monitoring system for cardiovascular diseases. World Health Stat Annu 1989;27.
19. Cambien F, Poirier O, Leceff L, Evans A, Cambou JP Arveiler D, Luc G, Bard JM, Bara L, Richard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641.
20. Scarabin PY, van Dreden P, Bonithon-Kop C, Orssaud G Bara L, Conard J, Samama M. Age-related changes in factor VII activation in healthy women. Clin Science 1988;75:341.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Colton T. Statistics in medicine. Boston, USA: Little Brown & Co, 1974;153.
23. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076.
24. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscl Thromb 1994;14:54.
25. Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JK, Meade TW, Martin JC Imeson JD, Cooper JA, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemostas 1994;71:38.
26. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1992;81:734.
27. Meilahn E, Humphries S, Ferrell R, Kiss J, Green F Temple A, Kuller L. Genetic determination of coagulation factor VIIc levels among healthy middle-aged women. Thromb Haemostas 1995;73:625.